Updates are available Correction dated 2025-02-28
Click to view Correction: https://doi.org/10.1245/s10434-025-17093-3
-
Authors
Improta, Luca https://orcid.org/0000-0002-8915-1168
Pasquali, Sandro
Valeri, Sergio
Gronchi, Alessandro
-
Funding
Funding for this research was provided by:
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (FRRB-584-797)
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (60)
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (GR-2019-12369175)
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Institutional grant BRI2017)
Ministero della Salute (“5x1000 Founds” – 2016)
Associazione Italiana per la Ricerca sul Cancro ([ID #24297]/Cancer Research UK [C56167/A29363]/Fun)
- License Information
-
More Information
Article History
Received: 14 March 2023
Accepted: 14 March 2023
First Online: 10 April 2023
Change Date: 28 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-025-17093-3
Disclosure
: A.G. received compensation for Ad Boards from Novartis, Bayer, Lilly, PharmaMar, and SpringWorks; honoraria from PharmaMar and Deciphera; and research grants from PharmaMar and Nanobiotix. The other authors have declared that no competing interests exist.
